Deep Dive: Deep Dive Into CD38 Therapy for Multiple Myeloma

Thomas G. Martin, MD discusses the research around CD38 antibody therapy for multiple myeloma, how they compare to approved agent and potential triplet and quadruplet combinations for the future.